STAAR Surgical Company

Case Form

Find Out if You Potentially Qualify for a Financial Reward by filling out the form.












The submission of this form does not create an attorney-client relationship.

Investigation Details

Staar reported disappointing earnings for Q4 2024, blaming the results on weak demand in China and a drop in refractive procedures.

Following this news, shares of Staar fell over 24% on February 12, 2025. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.